Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Catastrophic Antiphospholipid Syndrome with Pulmonary Hemorrhage: A Case Report

Joy-Ann Tabanor, MD, Hyun Bae, MD, Girish Sonpal, MD, & Karlene Williams, MD  |  Issue: August 2015  |  August 17, 2015

Red blood cells in the alveoli of a human lung on a scanning electron micrograph.

Red blood cells in the alveoli of a human lung on a scanning electron micrograph.
Image Credit: Ron Boardman/Life Science Image/FLPA/Science Source

Antiphospholipid syndrome (APS) is an autoimmune condition characterized by hypercoagulability often manifested as recurrent thrombosis or pregnancy complications, with persistently circulating antiphospholipid (aPL) antibodies or lupus anticoagulant. Catastrophic APS (CAPS), also known as Asherson syndrome, occurs in less than 1% of cases of APS and involves occlusive microangiopathy in at least three organ systems.1

Case Report

We report the case of a 43-year-old Guatemalan male with no significant past medical history who presented with a six-month history of progressive dyspnea, pleuritic chest pain and intermittent hemoptysis. On the day of presentation, he had sudden worsening of his cough and shortness of breath with frank hemoptysis. He had no bleeding or bruising at other sites. He also reported decreased appetite and increased fatigability, and had lost about 25 lbs. in the past year. He had no fever, chills or night sweats. There were no sick contacts, and he had not traveled recently. He had no history of prior surgical procedures and takes no medication except for the inhalers that were prescribed recently by another practitioner. There were no known drug allergies and no family history of cancer, bleeding disorders or other illnesses. He had a 10 pack-year history of cigarette smoking and quit about one month before presentation due to his progressive dyspnea. He used alcohol on the weekends, but did not use illicit drugs. He worked in a feather dye factory for 15 years, where he was exposed to sulfuric acid and ammonia.

Table 1: Initial Investigations

(click for larger image)
Table 1: Initial Investigations

On presentation, he was tachypneic, tachycardic, afebrile and normotensive, with no orthostatic change. In the emergency department, he was noted to have a cough productive of frothy bright red sputum. Oxygen saturation was 91% while breathing ambient air. His physical examination was significant for bilateral crackles and wheezing on lung examination and mild hepatomegaly. He had no lymphadenopathy. Initial investigations (see Table 1) revealed anemia, thrombocytopenia, mild leukocytosis, an activated partial thromboplastin time (aPTT) of 77.5 seconds, prothrombin time (PT) of 15.7 seconds and an international normalized ratio (INR) of 1.73. His electrocardiogram showed sinus tachycardia at a rate of 143 beats per minute without ST changes, and his chest radiograph showed bilateral predominantly perihilar alveolar opacities.

Hemorrhagic bronchoalveolar lavage fluid was sent for culture, cytology and tests for pneumocystis jirovecii and acid fast bacilli.

Hemorrhagic bronchoalveolar lavage fluid was sent for culture, cytology and tests for pneumocystis jirovecii and acid fast bacilli.
Image Credit: saipin ponchalee/shutterstock.com

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Antiphospholipid Antibody Syndrome (APS)catastrophic antiphospholipid syndromeClinicalDiagnosishemorrhageHughes Syndromeoutcomepatient carePulmonary

Related Articles

    APS: What Rheumatologists Should Know about Hughes Syndrome

    February 17, 2016

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

    Antiphospholipid Antibody Testing Update

    January 13, 2012

    Successes, challenges, and controversies of diagnostic methods for APS

    Why Antiphospholipid Antibody Syndrome Should Be On Your Radar

    February 1, 2014

    With a wide range of clinical manifestations and frequent occurrence among rheumatology patients, APS is one for rheumatologists to watch

    Put Hughes Syndrome on Your Radar

    April 1, 2007

    Diagnosis of antiphospholipid syndrome is increasing. Here’s how to recognize and treat it

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences